V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002520 | 240005181 | 1.63 | 95.1 | Curative (C) | null | 2016-07-28 | null | null | null | ALL UKALL2011 IND B | 100018474 |
| 240002522 | 240005182 | 1.84 | 76.4 | null | 2017-06-28 | 2017-07-01 | null | 02 | null | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 100113108 |
| 240002524 | 240005183 | 1.7 | 74.9 | null | null | 2019-03-15 | null | null | null | AML MYECHILD | 101135328 |
| 240002525 | 240005184 | 1.62 | 33.6 | null | null | 2019-08-31 | null | N | null | CISPLATIN + GEMCITABINE | 101402408 |
| 240002526 | 240005185 | 1.64 | 92 | null | 2019-09-29 | 2019-10-15 | CARFILZOMIB + LENALIDOMIDE | 02 | null | RUXOLITINIB | 101512007 |
| 240002527 | 240005186 | 0 | 44 | null | 2020-01-19 | 2020-01-23 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 02 | null | METHOTREXATE INTRATHECAL | 101474928 |
| 240002528 | 240005187 | null | 56.8 | 03 | null | 2016-07-05 | null | N | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101529663 |
| 240002529 | 240005188 | 1.78 | 68.8 | 03 | 2020-02-07 | 2020-02-14 | IBRUTINIB | 02 | N | CYTARABINE HIGH DOSE | 101794967 |
| 240002530 | 240005189 | null | null | Curative (C) | 2016-01-31 | 2016-02-27 | Enzalutamide | 02 | N | VEDEX | 101456655 |
| 240002531 | 240005190 | 1.8 | 55.7 | null | null | 2018-01-04 | null | null | null | CYTARABINE INTRATHECAL | 101194161 |
| 240002536 | 240005194 | 1.9 | 91.7 | Curative (C) | null | 2016-06-21 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 02 | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100869746 |
| 240002537 | 240005195 | 1.56 | 7.4 | Curative (C) | null | 2019-03-02 | IDELALISIB | null | N | CYTARABINE + DAUNORUBICIN | 101641673 |
| 240002538 | 240005196 | 1.69 | 42 | Curative (C) | 2017-07-24 | 2017-07-28 | null | 02 | null | AML MYECHILD 01 FLA-IDARUBICIN | 100878630 |
| 240002539 | 240005197 | 0 | 9.95 | null | null | 2018-05-21 | CISPLATIN + GEMCITABINE | 01 | null | CLADRIBINE | 100615225 |
| 240002540 | 240005198 | 1.8 | 65.7 | Curative (C) | 2018-03-15 | 2018-04-01 | ALL UKALL2011 Del Int C Recon PAsp | 02 | null | ANAGRELIDE | 101825739 |
| 240002542 | 240005199 | 1.69 | 66.3 | null | 2018-03-05 | 2018-05-11 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | null | ALL UKALL2011 STD BFM CONS B | 101652203 |
| 240002543 | 240005200 | 1.58 | 86.9 | null | null | 2018-04-15 | DA 3+8 | N | null | RUXOLITINIB | 100371794 |
| 240002544 | 240005201 | 1.56 | 86.8 | Curative (C) | 2020-03-10 | 2020-03-11 | null | 01 | N | METHOTREXATE INTRATHECAL | 100336254 |
| 240002546 | 240005203 | 0 | 71.5 | Curative (C) | null | 2019-04-02 | CVP R | null | N | AML MYECHILD | 100372532 |
| 240002547 | 240005204 | 1.73 | 100.9 | null | 2017-05-31 | 2017-05-31 | R CODOX M | 02 | null | ANAGRELIDE | 100035240 |
| 240002548 | 240005205 | 1.67 | 63.4 | 03 | 2018-01-30 | 2018-01-30 | OXALIPLATIN | N | N | VENETOCLAX | 101115927 |
| 240002549 | 240005206 | 1.57 | 73 | null | null | 2020-05-02 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100532134 |
| 240002550 | 240005207 | 0 | 20.1 | Palliative (P) | 2016-06-17 | 2016-06-23 | ATG + Busulfan + Fludarabine | 02 | N | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101385763 |
| 240002551 | 240005208 | 1.71 | 84.3 | null | 2018-12-23 | 2018-12-28 | PEG INTERFERON | N | null | ANAGRELIDE | 101669730 |
| 240002553 | 240005210 | null | 72 | Disease modification (D) | 2016-05-13 | 2017-04-24 | METHOTREXATE + PEGASPARGASE | N | null | GEMTUZUMAB OZOGAMICIN | 100040788 |
| 240002554 | 240005211 | 1.5 | 65 | Curative (C) | 2019-06-15 | 2019-07-05 | null | 02 | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100006443 |
| 240002555 | 240005212 | 1.62 | 133 | Curative (C) | 2019-06-11 | 2019-06-12 | FLAG + Idarubicin | Y | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE | 100371230 |
| 240002556 | 240005213 | 1.93 | 95.1 | Curative (C) | 2019-07-08 | 2019-09-16 | ALL UKALL2011 Maintenance A1 | 02 | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100977846 |
| 240002557 | 240005214 | 1.57 | 60.1 | null | 2016-05-01 | 2016-05-04 | null | 02 | null | FLAIR TRIAL | 101559226 |
| 240002559 | 240005216 | 1.68 | 84.8 | Curative (C) | null | 2017-11-27 | Cyclophosphamide High Dose | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100555913 |
| 240002560 | 240005217 | 1.65 | 80 | Curative (C) | null | 2018-10-21 | null | 01 | N | CLADRIBINE | 100210667 |
| 240002561 | 240005218 | 1.59 | 52.1 | null | 2021-07-10 | 2021-07-10 | IBRUTINIB | N | null | NIVOLUMAB | 101126037 |
| 240002562 | 240005219 | 1.69 | 64 | null | 2019-05-17 | 2019-05-26 | BUSULFAN | N | null | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 100461868 |
| 240002563 | 240005220 | 1.65 | 71.6 | null | null | 2018-05-09 | CODOX M | null | null | AML MYECHILD 01 IT CYT | 100236291 |
| 240002565 | 240005221 | 1.75 | 141 | null | 2018-06-11 | 2018-08-19 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | Y | null | AML MYECHILD 01 TRIPLE IT | 100932525 |
| 240002566 | 240005222 | 0 | 76.8 | null | 2021-03-17 | 2021-03-18 | FLUDARABINE + MELPHALAN | 02 | null | INTERFERON ALFA | 101486867 |
| 240002569 | 240005225 | 1.64 | 78.7 | Palliative (P) | 2019-01-09 | 2019-01-09 | null | 02 | N | CLADRIBINE | 100645679 |
| 240002571 | 240005226 | 1.76 | 69 | Curative (C) | 2020-10-07 | 2020-10-20 | Paclitaxel 7 day | 02 | null | IMATINIB | 101140289 |
| 240002572 | 240005227 | 1.79 | 63 | Curative (C) | 2018-07-07 | 2018-07-14 | null | 02 | N | TRIAL | 101846845 |
| 240002574 | 240005229 | 1.85 | 16.5 | 03 | 2019-06-28 | 2019-07-02 | Venetoclax | 02 | N | AML MYECHILD 01 IT CYT | 100213468 |
| 240002576 | 240005230 | null | 60 | 03 | 2020-05-02 | 2020-05-03 | CISPLATIN + GEMCITABINE | 01 | N | RITUXIMAB + VENETOCLAX | 100397262 |
| 240002577 | 240005231 | 1.71 | 86 | Curative (C) | 2016-12-27 | 2017-01-07 | null | N | null | FLAIR TRIAL | 101309020 |
| 240002581 | 240005235 | 1.84 | 106 | null | 2020-02-26 | 2020-02-27 | ALL UKALL2011 Aug BFM Cons C PegAsp | 01 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101520123 |
| 240002582 | 240005236 | 1.78 | 76.4 | 03 | 2019-08-17 | 2019-08-21 | null | 02 | N | TRIPLE INTRATHECAL | 100022375 |
| 240002583 | 240005237 | 1.69 | 60 | null | null | 2018-08-14 | Cyclophosphamide+Fludara+TBI Allo | Y | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100560456 |
| 240002585 | 240005239 | 1.77 | 21.35 | Palliative (P) | null | 2019-12-07 | FCR Oral - Cycle 2 onwards | 01 | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 101109411 |
| 240002587 | 240005240 | 1.69 | 16.2 | Curative (C) | null | 2018-04-15 | CHOP - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 100472245 |
| 240002593 | 240005245 | 1.68 | 58.6 | Curative (C) | 2019-10-15 | 2019-10-17 | AML Interim Guidelines FLAG-Ida | 02 | N | AML MYECHILD 01 IT CYT | 100543603 |
| 240002594 | 240005246 | 0 | 35.1 | null | null | 2017-10-05 | FLAG + Idarubicin | null | null | BUSULFAN | 101676444 |
| 240002596 | 240005247 | 1.78 | 88.8 | null | 2016-03-27 | 2016-04-01 | null | 02 | null | CNS LOW GRADE GLIOMA VINBLASTINE | 100426877 |